KRBPQ (KRBPQ) Stock Price & Analysis
KRBPQ (KRBPQ) rose 0.00% to USD 0 as of June 10, 2026 at 05:06 UTC, according to Nexqual real-time market data.
KRBPQ last closed at USD 0; the session ranged USD 0.01–0.01 on volume of 10,000 shares. Market capitalization is $265, with a 52-week range of USD 0–0.1 (PNK). Source: Nexqual, June 10, 2026 at 05:06 UTC.
Key Statistics (as of June 10, 2026 at 05:06 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0.01 |
| Day Range | USD 0.01 – 0.01 |
| 52-Week Range | USD 0 – 0.1 |
| Volume | 10,000 shares |
| Market Cap | $265 |
| Exchange | PNK |
Technical Analysis (KRBPQ)
Nexqual's technical model rates KRBPQ "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 05:06 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (KRBPQ)
Wall Street analysts rate KRBPQ "None", per Nexqual as of June 10, 2026 at 05:06 UTC.
| Consensus Rating | None |
|---|
Earnings (KRBPQ)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2022-09-30 | USD -15.9 vs est -16.8 ▲ beat |
| 2022-06-30 | USD -16.2 vs est -12.3 ▼ miss |
| 2022-03-31 | USD -14.4 vs est -8.7 ▼ miss |
| 2021-12-31 | USD -21.51 vs est -11.4 ▼ miss |
Source: Nexqual, June 10, 2026 at 05:06 UTC.
Financials & Fundamentals (KRBPQ)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.16 |
| Total Cash | $1.14M |
| Total Debt | $14.57M |
| Free Cash Flow | $-14.84M |
Source: Nexqual, June 10, 2026 at 05:06 UTC.
Financial Health Score (KRBPQ)
Nexqual rates KRBPQ's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 05:06 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $1M cash vs $15M debt |
| Cash Flow | Weak — Operating cash flow -$19M |
| Efficiency | Mixed — No data |
Ownership (KRBPQ)
| Insider Ownership | +2.29% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 2.65M |
| Float | 1.19M |
| Short % of Float | +6.82% |
Source: Nexqual, June 10, 2026 at 05:06 UTC.
Leadership (KRBPQ)
KRBPQ is led by Pietro Bersani (age 57), Chief Executive Officer, per Nexqual as of June 10, 2026 at 05:06 UTC.
| Chief Executive Officer | Pietro Bersani (age 57) |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ARDS | Aridis Pharmaceuticals Inc. | USD 0 | ▲ 0% |
| AFIB | Acutus Medical Inc. | USD 0 | ▲ 0% |
| PBLA | Panbela Therapeutics, Inc. | USD 0.01 | ▲ 0% |
| REVB | Revelation Biosciences, Inc. | USD 1.04 | ▲ 5.05% |
| LIXT | Lixte Biotechnology Holdings, I | USD 6.87 | ▼ 1.86% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:06 UTC. This page is informational and not investment advice.